Bacterial control of host gene expression through RNA polymerase II

Journal of Clinical Investigation

Volumn 123, Issue 6, 2013, Pages 2366-2379

  Lutay, Nataliya ^a   Ambite, Ines ^a   Hernandez, Jenny Grönberg ^a   Rydström, Gustav ^a   Ragnarsdóttir, Bryndís ^a   Puthia, Manoj ^a   Nadeem, Aftab ^a   Zhang, Jingyao ^b,d   Storm, Petter ^a   Dobrindt, Ulrich ^c   Wullt, Björn ^a   Svanborg, Catharina ^a  

^a LUND UNIVERSITY   (Sweden)

^b Agency for Science   (Singapore)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d GENOME INSTITUTE OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; RNA POLYMERASE II; TOLL LIKE RECEPTOR;

ACUTE PYELONEPHRITIS; ARTICLE; ASYMPTOMATIC BACTERIURIA; BACTERIAL STRAIN; ESCHERICHIA COLI; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INOCULATION; INTESTINE EPITHELIUM CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ASYMPTOMATIC INFECTIONS; BACTERIURIA; CELLS, CULTURED; ENZYME REPRESSION; EPITHELIAL CELLS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; GENE EXPRESSION; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PYELONEPHRITIS; RNA POLYMERASE II; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; URINARY TRACT INFECTIONS;

EID: 84878526368     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI66451     Document Type: Article

References (60)

1. Pamer EG. Immune responses to commensal and environmental microbes. Nat Immunol. 2007; 8(11):1173-1178.
2. Xu J, et al. Evolution of symbiotic bacteria in the distal human intestine. PLoS Biol. 2007;5(7):e156.
3. Rautava S, Walker WA. Commensal bacteria and epithelial cross talk in the developing intestine. Curr Gastroenterol Rep. 2007;9(5):385-392.
4. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science. 2001;291(5505):881-884.
5. Ragnarsdottir B, Lutay N, Gronberg-Hernandez J, Koves B, Svanborg C. Genetics of innate immunity and UTI susceptibility. Nat Rev Urol. 2011; 8(8):449-468.
6. Serruto D, Rappuoli R, Scarselli M, Gros P, van Strijp JA. Molecular mechanisms of complement evasion: learning from staphylococci and meningococci. Nat Rev Microbiol. 2010;8(6):393-399.
7. Oelschlaeger TA, Dobrindt U, Hacker J. Virulence factors of uropathogens. Curr Opin Urol. 2002; 12(1):33-38.
8. Cirl C, et al. Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins. Nat Med. 2008;14(4):399-406.
9. Fischer H, et al. Pathogen specific, IRF3-dependent signaling and innate resistance to human kidney infection. PLoS Pathog. 2010;6(9):e1001109.
10. Svanborg-Edén C, Hanson L, Jodal U, Lindberg U, Sohl-Åkelund A. Variable adherence to normal urinary tract epithelial cells of Escherichia coli strains associated with various forms of urinary tract infection. Lancet. 1976;1(7984):490-492.
11. Bergsten G, Wullt B, Svanborg C. Escherichia coli, fimbriae, bacterial persistence and host response induction in the human urinary tract. Int J Med Microbiol. 2005;295(6-7):487-502.
12. Kunin C. Urinary Tract Infections: Detection, Prevention and Management. Baltimore, Maryland, USA: Williams and Wilkins; 1997.
13. Zdziarski J, et al. Host imprints on bacterial genomes - rapid, divergent evolution in individual patients. PLoS Pathog. 2010;6(8):e1001078.
14. Zdziarski J, Svanborg C, Wullt B, Hacker J, Dobrindt U. Molecular basis of commensalism in the urinary tract: low virulence or virulence attenuation? Infect Immun. 2008;76(2):695-703.
15. Agace WW, Hedges SR, Ceska M, Svanborg C. Interleukin-8 and the neutrophil response to mucosal gram-negative infection. J Clin Invest. 1993; 92(2):780-785.
16. Wullt B, et al. P fimbriae enhance the early establishment of Escherichia coli in the human urinary tract. Mol Microbiol. 2000;38(3):456-464.
17. Sunden F, Hakansson L, Ljunggren E, Wullt B. Escherichia coli 83972 bacteriuria protects against recurrent lower urinary tract infections in patients with incomplete bladder emptying. J Urol. 2010; 184(1):179-185.
18. Hernandez JG, Sunden F, Connolly J, Svanborg C, Wullt B. Genetic control of the variable innate immune response to asymptomatic bacteriuria. PLoS One. 2011;6(11):e28289.
19. Jacobson SH, Lu Y, Brauner A. Soluble interleukin-6 receptor, interleukin-10 and granulocyte colony-stimulating factor in acute pyelonephritis: relationship to markers of bacterial virulence and renal function. Nephron. 1998;80(4):401-407.
20. Sheu JN, et al. Serum and urine levels of interleukin-6 and interleukin-8 in children with acute pyelonephritis. Cytokine. 2006;36(5-6):276-282.
21. Hedlund M, Svensson M, Nilsson A, Duan RD, Svanborg C. Role of the ceramide-signaling pathway in cytokine responses to P-fimbriated Escherichia coli. J Exp Med. 1996;183(3):1037-1044.
22. Chua SW, Vijayakumar P, Nissom PM, Yam CY, Wong VV, Yang H. A novel normalization method for effective removal of systematic variation in microarray data. Nucleic Acids Res. 2006;34(5):e38.
23. Schaffar G, et al. Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation. Mol Cell. 2004;15(1):95-105.
24. Jeronimo C, et al. Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme. Mol Cell. 2007;27(2):262-274.
25. Egloff S, Van Herreweghe E, Kiss T. Regulation of polymerase II transcription by 7SK snRNA: two distinct RNA elements direct P-TEFb and HEXIM1 binding. Mol Cell Biol. 2006;26(2):630-642.
26. Lee Y, et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004;23(20):4051-4060.
27. Ai J, et al. A human homolog of mouse Lbh gene, hLBH, expresses in heart and activates SRE and AP-1 mediated MAPK signaling pathway. Mol Biol Rep. 2008;35(2):179-187.
28. Kawai S, Abiko Y, Amano A. Odd-skipped related 2 regulates genes related to proliferation and development. Biochem Biophys Res Commun. 2010; 398(2):184-190.
29. Miyamoto-Sato E, et al. A comprehensive resource of interacting protein regions for refining human transcription factor networks. PLoS One. 2010; 5(2):e9289.
30. van Wely KH, et al. The MN1 oncoprotein synergizes with coactivators RAC3 and p300 in RAR-RXR-mediated transcription. Oncogene. 2003;22(5):699-709.
31. Mitchell PJ, Wang C, Tjian R. Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen. Cell. 1987;50(6):847-861.
32. Wu K, et al. Cell fate determination factor DACH1 inhibits c-Jun-induced contact-independent growth. Mol Biol Cell. 2007;18(3):755-767.
33. Rampalli S, Pavithra L, Bhatt A, Kundu TK, Chattopadhyay S. Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex. Mol Cell Biol. 2005; 25(19):8415-8429.
34. Pellizzoni L, Charroux B, Rappsilber J, Mann M, Dreyfuss G. A functional interaction between the survival motor neuron complex and RNA polymerase II. J Cell Biol. 2001;152(1):75-85.
35. Takata A, et al. A miRNA machinery component DDX20 controls NF-kappaB via microRNA-140 function. Biochem Biophys Res Commun. 2012; 420(3):564-569.
36. Tarn WY, Steitz JA. Highly diverged U4 and U6 small nuclear RNAs required for splicing rare AT-AC introns. Science. 1996;273(5283):1824-1832.
37. Yang HS, et al. The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol Cell Biol. 2003;23(1):26-37.
38. Fuda NJ, Ardehali MB, Lis JT. Defining mechanisms that regulate RNA polymerase II transcription in vivo. Nature. 2009;461(7261):186-192.
39. Zandomeni RO. Kinetics of inhibition by 5,6-dichloro-1-beta-D- ribofuranosylbenzimidazole on calf thymus casein kinase II. Biochem J. 1989; 262(2):469-473.
40. Palancade B, Dubois MF, Bensaude O. FCP1 phosphorylation by casein kinase 2 enhances binding to TFIIF and RNA polymerase II carboxyl-terminal domain phosphatase activity. J Biol Chem. 2002; 277(39):36061-36067.
41. Yankulov K, Yamashita K, Roy R, Egly JM, Bentley DL. The transcriptional elongation inhibitor 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits transcription factor IIH-associated protein kinase. J Biol Chem. 1995;270(41):23922-23925.
42. Shanware NP, Trinh AT, Williams LM, Tibbetts RS. Coregulated ataxia telangiectasia-mutated and casein kinase sites modulate cAMP-response element-binding protein-coactivator interactions in response to DNA damage. J Biol Chem. 2007; 282(9):6283-6291.
43. Gupta P, Prywes R. ATF1 phosphorylation by the ERK MAPK pathway is required for epidermal growth factor-induced c-jun expression. J Biol Chem. 2002;277(52):50550-50556.
44. Fischer H, Ellström P, Ekström K, Gustafsson L, Gustafsson M, Svanborg C. Ceramide as a TLR4 agonist; a putative signalling intermediate between sphingolipid receptors for microbial ligands and TLR4. Cell Microbiol. 2007;9(5):1239-1251.
45. Lindberg U, Claesson I, Hanson LA, Jodal U. Asymptomatic bacteriuria in schoolgirls. VIII. Clinical course during a 3-year follow-up. J Pediatr. 1978;92(2):194-199.
46. Salvador E, et al. Asymptomatic bacteriuria E. coli isolates from healthy individuals versus hospital patients: long-term bladder colonization selects for attenuated virulence phenotypes. Infect Immun. 2012;80(2):668-678.
47. Conaway RC, Conaway JW. Function and regulation of the Mediator complex. Curr Opin Genet Dev. 2011;21(2):225-230.
48. Selth LA, Sigurdsson S, Svejstrup JQ. Transcript Elongation by RNA Polymerase II. Annu Rev Biochem. 2010;79:271-293.
49. O'Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep. 2006;7(7):688-693.
50. Walker WA. Mechanisms of action of probiotics. Clin Infect Dis. 2008;46(suppl 2):S87-S91.
51. Xu J, Gordon JI. Honor thy symbionts. Proc Natl Acad Sci U S A. 2003;100(18):10452-10459.
52. Ichinohe T, et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc Natl Acad Sci U S A. 2011; 108(13):5354-5359.
53. Munakata K, et al. Importance of the interferon-alpha system in murine large intestine indicated by microarray analysis of commensal bacteria-induced immunological changes. BMC Genomics. 2008; 9:192.
54. Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol. 1997;159(4):1739-1745.
55. Resta-Lenert S, Barrett KE. Probiotics and commensals reverse TNF-α- and IFN-γ-induced dysfunction in human intestinal epithelial cells. Gastroenterology. 2006;130(3):731-746.
56. Dubuquoy L, et al. Impaired expression of peroxisome proliferator- activated receptor gamma in ulcerative colitis. Gastroenterology. 2003; 124(5):1265-1276.
57. Heijtz RD, et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A. 2011;108(7):3047-3052.
58. Plos K, et al. Intestinal carriage of P fimbriated Escherichia coli and the susceptibility to urinary tract infection in young children. J Infect Dis. 1995; 171(3):625-631.
59. Nielubowicz GR, Mobley HL. Host-pathogen interactions in urinary tract infection. Nat Rev Urol. 2010; 7(8):430-441.
60. Huang da W, et al. The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol. 2007;8(9):R183.